Page last updated: 2024-10-28

phenelzine and Refractory Depression

phenelzine has been researched along with Refractory Depression in 2 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Research Excerpts

ExcerptRelevanceReference
" By study phase, Eight of 27 (30%) patients remitted with initial dosing of tranylcypromine up to 60 mg/d, 6/18 (33%) remitted with above PDR dosing of tranylcypromine up to 120 mg/d, and 1/6 (17%) to adding dextroamphetamine."2.79How treatable is refractory depression? ( Deliyannides, DA; McGrath, PJ; Stewart, JW, 2014)
"Evidence supports the use of MAOIs in major depressive disorder, certain anxiety disorders and, to lesser extent, bipolar depression."2.53MAOIs - does the evidence warrant their resurrection? ( Bosanac, P; Castle, D; Menkes, D, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stewart, JW1
Deliyannides, DA1
McGrath, PJ1
Menkes, D1
Bosanac, P1
Castle, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Pilot Study of Treatment for Refractory Depression With Sequential Trials of Tranylcypromine, Tranylcypromine Plus Dextroamphetamine, Tranylcypromine Plus Triiodothyronine.[NCT00296686]Phase 431 participants (Actual)Interventional2001-09-30Terminated (stopped due to Study is no longer funded.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for phenelzine and Refractory Depression

ArticleYear
MAOIs - does the evidence warrant their resurrection?
    Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2016, Volume: 24, Issue:4

    Topics: Anxiety Disorders; Bipolar Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resi

2016

Trials

1 trial available for phenelzine and Refractory Depression

ArticleYear
How treatable is refractory depression?
    Journal of affective disorders, 2014, Volume: 167

    Topics: Adult; Antidepressive Agents; Central Nervous System Stimulants; Depressive Disorder, Major; Depress

2014